Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled H057 for acute exacerbations of bronchiectasis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• H057

Snippet

Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. | Conditions: Acute Exacerbations of Bronchiectasis | Phase 2 | Status: NOT_YET_RECRUITING